HL7 FHIR® Implementation Guide: Breast Cancer Data, Release 1 - US Realm (Draft for Comment)
This page is part of the Breast Cancer Data Logical Models and FHIR Profiles (v0.1.0: STU 1 Draft) based on FHIR R3. . For a full list of available versions, see the Directory of published versions 
| Name | Definition |
| AnatomicalDirectionCS | Anatomical location or specimen further detailing directionality. Codes are from NCI |
| BreastCancerStageCS | Codes representing the overall stage of the cancer, based on criteria defined by the staging system being used. The preferred staging system is American Joint Committee on Cancer, 8th Edition, Breast Cancer Chapter. Codes and descriptions have been redacted due to copyright restrictions. |
| BreastCancerTypeCS | Histologic types of breast cancer. Codes are drawn from ICD-O-3. Codes are presented as local codes due to the lack of a ICD-O-3 terminology server available to the FHIR IG publisher. |
| BreastSiteCS | Topography of the breast. Codes are drawn from ICD-O-3. Codes are presented as local codes due to the lack of a ICD-O-3 terminology server available to the FHIR IG publisher. |
| BreastSpecimenCollectionMethodCS | The surgical method used to obtain the tissue sample. |
| BreastSpecimenTypeCS | The type of specimen obtained from the breast. |
| DiagnosticServiceCS | The type of laboratory service used in producing a laboratory result |
| ExceptionValueCS | Reasons that a value associated with a test or other finding is missing. Extended set based on http://hl7.org/fhir/ValueSet/observation-valueabsentreason |
| HER2IHCMethodCS | Value set containing methods of determining HER2 status by immunohistochemistry |
| HER2ISHMethodCS | Value set containing In Situ Hybridization methods of determining HER2 status |
| HER2StatusCS | HER2 status overall result |
| MammaprintRiskScoreInterpretationCS | Intepretation of Mammaprint Recurrence Score |
| MitoticCountScoreCS | Value set containing the scores for Nottingham Histologic Score Mitotic Rate |
| MorphologyBehaviorCS | The morphologic behavior of the cancer. These are the suffix to the ICD-O-3 histologic type codes. Codes are presented as local codes due to the lack of a ICD-O-3 terminology server available to the FHIR IG publisher. |
| NuclearGradeCS | The nuclear grade describes how closely the nuclei of cancer cells look like the nuclei of normal breast cells. In general, the higher the nuclear grade, the more abnormal the nuclei are and the more aggressive the tumor cells tend to be. The nuclear grade is a part of overall tumor grade. |
| OncotypeDxDCISRiskScoreInterpretationCS | Intepretation of OncotypeDX DCIS (Ductal Carcinoma In Situ) Recurrence Score |
| OncotypeDxInvasiveRiskScoreInterpretationCS | Intepretation of OncotypeDX Recurrence Score for invasive cancers. |
| PositiveNegativeCS | Value set containing the values positive and negative. Values are from National Library of Medicine Metathesaurus. |
| PositiveNegativeEquivocalCS | Interpretation of a test result as positive, negative or equivocal. |
| RecurrenceRiskScoreInterpretationCS | Interpretations of risk as high, intermediate, or low. Answer set taken from LOINC LL3198-0 |
| StageTimingPrefixCS | When staging was done, relative to treatment events. |
| StagingMethodCS | The methodology or standard used to assign the cancer's overall stage. |
| StainingIntensityCS | Part of the Allred scoring, based on the intensity of that staining, on a scale of 0 (Negative) to 3 (Strong). |
| YesNoUnknownCS | A simple value set containing the values Yes (or true), No (or false), and Unknown |